Bought
Maintained
Sold
Other funds holding ADNT
HHAM
Amundi's ADNT Position: Q2 2026 in Review
Amundi increased its Adient (ADNT) stake by 8.2% in Q2 2026, buying an estimated $252K and bringing the position to 154,790 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1102.
Amundi first reported a position in ADNT in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.89M in Q1 2026. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.
- Amundi held 154,790 shares of Adient worth $2.85M as of Q2 2026.
- Amundi bought 11,768 Adient shares in Q2 2026, an estimated $252K.
- Adient made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1102 holding.
- Amundi first reported a position in Adient in Q2 2025 and has held it in 5 quarters since.
- Amundi's Adient position peaked at $2.89M in Q1 2026.
- 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.